DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 02 · Volume 35 · March 2002 DOI: 10.1055/s-002-1702

Original Paper

  • 37
    Gaertner, I.; Gilot, C.; Heidrich, P.; Gaertner, H.-J.:

    A Case Control Study on Psychopharmacotherapy before Suicide Committed by 61 Psychiatric Inpatients

  • 44
    Müller-Oerlinghausen, B.; Roggenbach, J.:

    Concretism in Biological Suicide Research - Are We Eating the Menu Instead of the Meal?

  • 50
    Bondolfi, G.; Eap, C. B.; Bertschy, G.; Zullino, D.; Vermeulen, A.; Baumann, P.:

    The Effect of Fluoxetine on the Pharmacokinetics and Safety of Risperidone in Psychotic Patients

  • 57
    Müller-Vahl, K. R.; Schneider, U.; Koblenz, A.; Jöbges, M.; Kolbe, H.; Daldrup, T.; Emrich, H. M.:

    Treatment of Tourette's Syndrome with Δ9-Tetrahydrocannabinol (THC): A Randomized Crossover Trial

  • 62
    Yui, K.; Ikemoto, S.; Goto, K.; Nishijima, K.; Yoshino, T.; Ishiguro, T.:

    Spontaneous Recurrence of Methamphetamine-lnduced Paranoid-Hallucinatory States in Female Subjects: Susceptibility to Psychotic States and Implications for Relapse of Schizophrenia

    • Case Report

  • 72
    Scheschonka, A.; Bleich, St.; Buchwald, A. B.; Ruther, E.; Wiltfang, J.:

    Development of Obsessive-Compulsive Behaviour Following Cortisone Treatment

  • 75
    Pezawas, L.; Stamenkovic, M.; Aschauer, N.; Moffat, R.; Kasper, S.:

    Successful Treatment of Recurrent Brief Depression with Reboxetine - A Single Case Analysis

  • 77
    Haberfellner, E. M.:

    Sexual Dysfunction Caused by Reboxetine

  • 79
    Heinze, M.; Andreae, D.; Grohmann, R.:

    Rivastigmin and Impaired Motor Function

    • Letter to the Editor

  • 81
    Engfer, A.:

    Soyka M, Bottlender R, Möller H-J;
    Epidemiological Evidence for a
    Low Abuse Potential of Zolpidem; Pharmacopsychiatry 2000, 33:
    138 - 141

  • 81

    Author's reply